vs
Encompass Health Corp（EHC）とUbiquiti Inc.（UI）の財務データ比較。上の社名をクリックして会社を切り替えられます
Encompass Health Corpの直近四半期売上が大きい（$1.5B vs $814.9M、Ubiquiti Inc.の約1.9倍）。Ubiquiti Inc.の純利益率が高く（28.7% vs 9.5%、差は19.2%）。Ubiquiti Inc.の前年同期比売上増加率が高い（35.8% vs 9.9%）。Ubiquiti Inc.の直近四半期フリーキャッシュフローが多い（$260.3M vs $116.7M）。過去8四半期でUbiquiti Inc.の売上複合成長率が高い（28.6% vs 8.3%）
エンコンパスヘルスコーポレーション（旧Amcare、HealthSouth）は米国アラバマ州バーミンガムに本社を置く米国最大の入院リハビリサービス事業者で、39州とプエルトリコに173の入院リハビリ病院を展開し、脳卒中や神経疾患、心肺疾患、脳損傷から回復中の患者に専門的な治療とケアを提供している。
Ubiquiti Inc.は2003年に米国カリフォルニア州サンノゼで設立されたテクノロジー企業で、現在はニューヨークに本社を置いています。複数のブランドを展開し、企業および一般家庭向けの有線・無線データ通信機器の製造・販売を事業の柱としています。
EHC vs UI — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.5B | $814.9M |
| 純利益 | $146.1M | $233.6M |
| 粗利率 | — | 45.9% |
| 営業利益率 | 16.7% | 35.9% |
| 純利益率 | 9.5% | 28.7% |
| 売上前年比 | 9.9% | 35.8% |
| 純利益前年比 | 20.8% | 70.8% |
| EPS（希薄化後） | $1.43 | $3.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.5B | $814.9M | ||
| Q3 25 | $1.5B | $733.8M | ||
| Q2 25 | $1.5B | $759.2M | ||
| Q1 25 | $1.5B | $664.2M | ||
| Q4 24 | $1.4B | $599.9M | ||
| Q3 24 | $1.4B | $550.3M | ||
| Q2 24 | $1.3B | $507.5M | ||
| Q1 24 | $1.3B | $493.0M |
| Q4 25 | $146.1M | $233.6M | ||
| Q3 25 | $126.5M | $207.9M | ||
| Q2 25 | $142.1M | $266.7M | ||
| Q1 25 | $151.5M | $180.4M | ||
| Q4 24 | $120.9M | $136.8M | ||
| Q3 24 | $108.2M | $128.0M | ||
| Q2 24 | $114.1M | $103.8M | ||
| Q1 24 | $112.5M | $76.3M |
| Q4 25 | — | 45.9% | ||
| Q3 25 | — | 46.0% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | 44.5% | ||
| Q4 24 | — | 41.2% | ||
| Q3 24 | — | 42.1% | ||
| Q2 24 | — | 40.2% | ||
| Q1 24 | — | 35.3% |
| Q4 25 | 16.7% | 35.9% | ||
| Q3 25 | 14.9% | 35.7% | ||
| Q2 25 | 16.2% | 34.4% | ||
| Q1 25 | 16.4% | 34.2% | ||
| Q4 24 | 14.3% | 29.8% | ||
| Q3 24 | 13.6% | 30.7% | ||
| Q2 24 | 14.3% | 27.3% | ||
| Q1 24 | 13.6% | 22.6% |
| Q4 25 | 9.5% | 28.7% | ||
| Q3 25 | 8.6% | 28.3% | ||
| Q2 25 | 9.7% | 35.1% | ||
| Q1 25 | 10.4% | 27.2% | ||
| Q4 24 | 8.6% | 22.8% | ||
| Q3 24 | 8.0% | 23.3% | ||
| Q2 24 | 8.8% | 20.5% | ||
| Q1 24 | 8.5% | 15.5% |
| Q4 25 | $1.43 | $3.86 | ||
| Q3 25 | $1.24 | $3.43 | ||
| Q2 25 | $1.39 | $4.40 | ||
| Q1 25 | $1.48 | $2.98 | ||
| Q4 24 | $1.18 | $2.26 | ||
| Q3 24 | $1.06 | $2.12 | ||
| Q2 24 | $1.12 | $1.72 | ||
| Q1 24 | $1.10 | $1.26 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $72.2M | $302.8M |
| 総負債低いほど良い | $2.4B | $47.5M |
| 株主資本純資産 | $2.4B | $1.0B |
| 総資産 | $7.1B | $1.6B |
| 負債/資本比率低いほどレバレッジが低い | 1.00× | 0.05× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $72.2M | $302.8M | ||
| Q3 25 | $48.7M | $177.2M | ||
| Q2 25 | $99.1M | $149.7M | ||
| Q1 25 | $95.8M | $151.0M | ||
| Q4 24 | $85.4M | $133.1M | ||
| Q3 24 | $147.8M | $165.2M | ||
| Q2 24 | $154.4M | $126.3M | ||
| Q1 24 | $134.4M | $102.5M |
| Q4 25 | $2.4B | $47.5M | ||
| Q3 25 | $2.4B | $133.8M | ||
| Q2 25 | $2.3B | $250.0M | ||
| Q1 25 | $2.3B | $340.0M | ||
| Q4 24 | $2.4B | $406.3M | ||
| Q3 24 | $2.3B | $552.5M | ||
| Q2 24 | $2.7B | $708.1M | ||
| Q1 24 | $2.7B | $877.5M |
| Q4 25 | $2.4B | $1.0B | ||
| Q3 25 | $2.4B | $828.4M | ||
| Q2 25 | $2.3B | $668.3M | ||
| Q1 25 | $2.2B | $436.1M | ||
| Q4 24 | $2.1B | $290.4M | ||
| Q3 24 | $2.0B | $188.1M | ||
| Q2 24 | $1.8B | $95.1M | ||
| Q1 24 | $1.7B | $25.9M |
| Q4 25 | $7.1B | $1.6B | ||
| Q3 25 | $6.9B | $1.5B | ||
| Q2 25 | $6.8B | $1.5B | ||
| Q1 25 | $6.6B | $1.3B | ||
| Q4 24 | $6.5B | $1.2B | ||
| Q3 24 | $6.5B | $1.2B | ||
| Q2 24 | $6.4B | $1.2B | ||
| Q1 24 | $6.2B | $1.2B |
| Q4 25 | 1.00× | 0.05× | ||
| Q3 25 | 1.01× | 0.16× | ||
| Q2 25 | 1.02× | 0.37× | ||
| Q1 25 | 1.08× | 0.78× | ||
| Q4 24 | 1.14× | 1.40× | ||
| Q3 24 | 1.20× | 2.94× | ||
| Q2 24 | 1.46× | 7.45× | ||
| Q1 24 | 1.54× | 33.92× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $346.0M | $263.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $116.7M | $260.3M |
| FCFマージンFCF / 売上 | 7.6% | 31.9% |
| 設備投資強度設備投資 / 売上 | 14.8% | 0.4% |
| キャッシュ転換率営業CF / 純利益 | 2.37× | 1.13× |
| 直近12ヶ月FCF直近4四半期 | $439.2M | $699.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $346.0M | $263.9M | ||
| Q3 25 | $270.8M | $198.5M | ||
| Q2 25 | $270.2M | $130.4M | ||
| Q1 25 | $288.6M | $123.6M | ||
| Q4 24 | $278.8M | $152.4M | ||
| Q3 24 | $267.8M | $233.7M | ||
| Q2 24 | $217.4M | $231.4M | ||
| Q1 24 | $238.8M | $163.9M |
| Q4 25 | $116.7M | $260.3M | ||
| Q3 25 | $83.7M | $193.3M | ||
| Q2 25 | $113.3M | $125.2M | ||
| Q1 25 | $125.5M | $120.7M | ||
| Q4 24 | $80.1M | $150.4M | ||
| Q3 24 | $120.3M | $231.1M | ||
| Q2 24 | $60.5M | $229.5M | ||
| Q1 24 | $99.4M | $160.6M |
| Q4 25 | 7.6% | 31.9% | ||
| Q3 25 | 5.7% | 26.3% | ||
| Q2 25 | 7.8% | 16.5% | ||
| Q1 25 | 8.6% | 18.2% | ||
| Q4 24 | 5.7% | 25.1% | ||
| Q3 24 | 8.9% | 42.0% | ||
| Q2 24 | 4.6% | 45.2% | ||
| Q1 24 | 7.6% | 32.6% |
| Q4 25 | 14.8% | 0.4% | ||
| Q3 25 | 12.7% | 0.7% | ||
| Q2 25 | 10.8% | 0.7% | ||
| Q1 25 | 11.2% | 0.4% | ||
| Q4 24 | 14.1% | 0.3% | ||
| Q3 24 | 10.9% | 0.5% | ||
| Q2 24 | 12.1% | 0.4% | ||
| Q1 24 | 10.6% | 0.7% |
| Q4 25 | 2.37× | 1.13× | ||
| Q3 25 | 2.14× | 0.95× | ||
| Q2 25 | 1.90× | 0.49× | ||
| Q1 25 | 1.90× | 0.68× | ||
| Q4 24 | 2.31× | 1.11× | ||
| Q3 24 | 2.48× | 1.83× | ||
| Q2 24 | 1.91× | 2.23× | ||
| Q1 24 | 2.12× | 2.15× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
UI
| Enterprise Technology | $729.0M | 89% |
| Service Provider Technology | $85.9M | 11% |
